DEXA Predicts Diabetes in Obese Menopausal Women
By MedImaging International staff writers Posted on 13 Sep 2021 |
Image: Bone density measurements can also help diagnose diabetes in older women (Photo courtesy of Alamy)
Dual-energy x-ray absorptiometry (DEXA) beats traditional clinical obesity measures for predicting diabetes and heart disease in older women, according to a new study.
Researchers at Stanford University (CA, USA), the University of Illinois in Chicago (UIC; USA), and other institutions analyzed data on 9,744 postmenopausal women (50-79 years of age) who underwent a DEXA scan and were free of cardiovascular disease (CVD) and diabetes at baseline. The aim of the study was to see if DEXA estimates of adiposity in older women could improve risk prediction for cardiometabolic diseases better than the traditional surrogates - body mass index (BMI), waist circumference (WC), and waist-to-hip ratio (WHR).
The results revealed a total of 1,327 diabetes, 1,266 atherosclerotic CVD, and 292 heart failure (HF) cases, as well as 1,811 deaths from any cause accrued during a median follow-up of 17.2 years. The largest hazard ratio per adiposity measure for diabetes and atherosclerotic CVD was percentage of trunk fat (%TrF), which was also the only adiposity measure to demonstrate statistically significant improved concordance probability estimates over BMI, WC, and WHR. The study was published on August 31, 2021, in Mayo Clinic Proceedings.
“The single most striking finding of our multivariable analyses was the magnitude of association observed between %TrF and the risk of incident diabetes,” concluded lead author Deepika Laddu, PhD, of the University of Chicago. “Using DEXA to improve risk prediction for cardiometabolic diseases among patients already being screened for osteoporosis presumably would have little impact on cost of care, and has the potential to impact public health substantially.”
DEXA is a means of measuring bone mineral density (BMD) using spectral imaging. Two X-ray beams, with different energy levels, are aimed at the bones. When soft tissue absorption is subtracted, BMD can be determined from the absorption of each beam. DEXA is most often used to diagnose and monitor osteoporosis.
Related Links:
Stanford University
University of Illinois in Chicago
Researchers at Stanford University (CA, USA), the University of Illinois in Chicago (UIC; USA), and other institutions analyzed data on 9,744 postmenopausal women (50-79 years of age) who underwent a DEXA scan and were free of cardiovascular disease (CVD) and diabetes at baseline. The aim of the study was to see if DEXA estimates of adiposity in older women could improve risk prediction for cardiometabolic diseases better than the traditional surrogates - body mass index (BMI), waist circumference (WC), and waist-to-hip ratio (WHR).
The results revealed a total of 1,327 diabetes, 1,266 atherosclerotic CVD, and 292 heart failure (HF) cases, as well as 1,811 deaths from any cause accrued during a median follow-up of 17.2 years. The largest hazard ratio per adiposity measure for diabetes and atherosclerotic CVD was percentage of trunk fat (%TrF), which was also the only adiposity measure to demonstrate statistically significant improved concordance probability estimates over BMI, WC, and WHR. The study was published on August 31, 2021, in Mayo Clinic Proceedings.
“The single most striking finding of our multivariable analyses was the magnitude of association observed between %TrF and the risk of incident diabetes,” concluded lead author Deepika Laddu, PhD, of the University of Chicago. “Using DEXA to improve risk prediction for cardiometabolic diseases among patients already being screened for osteoporosis presumably would have little impact on cost of care, and has the potential to impact public health substantially.”
DEXA is a means of measuring bone mineral density (BMD) using spectral imaging. Two X-ray beams, with different energy levels, are aimed at the bones. When soft tissue absorption is subtracted, BMD can be determined from the absorption of each beam. DEXA is most often used to diagnose and monitor osteoporosis.
Related Links:
Stanford University
University of Illinois in Chicago
Latest General/Advanced Imaging News
- PET Scans Reveal Hidden Inflammation in Multiple Sclerosis Patients
- Artificial Intelligence Evaluates Cardiovascular Risk from CT Scans
- New AI Method Captures Uncertainty in Medical Images
- CT Coronary Angiography Reduces Need for Invasive Tests to Diagnose Coronary Artery Disease
- Novel Blood Test Could Reduce Need for PET Imaging of Patients with Alzheimer’s
- CT-Based Deep Learning Algorithm Accurately Differentiates Benign From Malignant Vertebral Fractures
- Minimally Invasive Procedure Could Help Patients Avoid Thyroid Surgery
- Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery
- AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning
- Imaging Technology Provides Ground-Breaking New Approach for Diagnosing and Treating Bowel Cancer
- CT Coronary Calcium Scoring Predicts Heart Attacks and Strokes
- AI Model Detects 90% of Lymphatic Cancer Cases from PET and CT Images
- Breakthrough Technology Revolutionizes Breast Imaging
- State-Of-The-Art System Enhances Accuracy of Image-Guided Diagnostic and Interventional Procedures
- Catheter-Based Device with New Cardiovascular Imaging Approach Offers Unprecedented View of Dangerous Plaques
- AI Model Draws Maps to Accurately Identify Tumors and Diseases in Medical Images